These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 29291456)

  • 1. Does age affect response to quinidine in patients with KCNT1 mutations? Report of three new cases and review of the literature.
    Abdelnour E; Gallentine W; McDonald M; Sachdev M; Jiang YH; Mikati MA
    Seizure; 2018 Feb; 55():1-3. PubMed ID: 29291456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinidine in the treatment of KCNT1-positive epilepsies.
    Mikati MA; Jiang YH; Carboni M; Shashi V; Petrovski S; Spillmann R; Milligan CJ; Li M; Grefe A; McConkie A; Berkovic S; Scheffer I; Mullen S; Bonner M; Petrou S; Goldstein D
    Ann Neurol; 2015 Dec; 78(6):995-9. PubMed ID: 26369628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy.
    Dilena R; DiFrancesco JC; Soldovieri MV; Giacobbe A; Ambrosino P; Mosca I; Galli MA; Guez S; Fumagalli M; Miceli F; Cattaneo D; Darra F; Gennaro E; Zara F; Striano P; Castellotti B; Gellera C; Varesio C; Veggiotti P; Taglialatela M
    Neurotherapeutics; 2018 Oct; 15(4):1112-1126. PubMed ID: 30112700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precision therapy for epilepsy due to
    Mullen SA; Carney PW; Roten A; Ching M; Lightfoot PA; Churilov L; Nair U; Li M; Berkovic SF; Petrou S; Scheffer IE
    Neurology; 2018 Jan; 90(1):e67-e72. PubMed ID: 29196578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two Patients With KCNT1-Related Epilepsy Responding to Phenobarbital and Potassium Bromide.
    Datta AN; Michoulas A; Guella I; ; Demos M
    J Child Neurol; 2019 Oct; 34(12):728-734. PubMed ID: 31208268
    [No Abstract]   [Full Text] [Related]  

  • 6. KCNT1-related epilepsy: An international multicenter cohort of 27 pediatric cases.
    Borlot F; Abushama A; Morrison-Levy N; Jain P; Puthenveettil Vinayan K; Abukhalid M; Aldhalaan HM; Almuzaini HS; Gulati S; Hershkovitz T; Konanki R; Lingappa L; Luat AF; Shafi S; Tabarki B; Thomas M; Yoganathan S; Alfadhel M; Arya R; Donner EJ; Ehaideb SN; Gowda VK; Jain V; Madaan P; Myers KA; Otsubo H; Panda P; Sahu JK; Sampaio LPB; Sharma S; Simard-Tremblay E; Zak M; Whitney R
    Epilepsia; 2020 Apr; 61(4):679-692. PubMed ID: 32167590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment Responsiveness in KCNT1-Related Epilepsy.
    Fitzgerald MP; Fiannacca M; Smith DM; Gertler TS; Gunning B; Syrbe S; Verbeek N; Stamberger H; Weckhuysen S; Ceulemans B; Schoonjans AS; Rossi M; Demarquay G; Lesca G; Olofsson K; Koolen DA; Hornemann F; Baulac S; Rubboli G; Minks KQ; Lee B; Helbig I; Dlugos D; Møller RS; Bearden D
    Neurotherapeutics; 2019 Jul; 16(3):848-857. PubMed ID: 31054119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinidine therapy and therapeutic drug monitoring in four patients with KCNT1 mutations.
    Yoshitomi S; Takahashi Y; Yamaguchi T; Oboshi T; Horino A; Ikeda H; Imai K; Okanishi T; Nakashima M; Saitsu H; Matsumoto N; Yoshimoto J; Fujita T; Ishii A; Hirose S; Inoue Y
    Epileptic Disord; 2019 Feb; 21(1):48-54. PubMed ID: 30782581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KCNT1-positive epilepsy of infancy with migrating focal seizures successfully treated with nonnarcotic antitussive drugs after treatment failure with quinidine: A case report.
    Takase C; Shirai K; Matsumura Y; Watanabe T; Watanabe A; Hirasawa-Inoue A; Mizuguchi T; Matsumoto N; Sugai K; Hayashi M
    Brain Dev; 2020 Sep; 42(8):607-611. PubMed ID: 32505479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of response to quinidine in KCNT1-related neonatal epilepsy.
    Numis AL; Nair U; Datta AN; Sands TT; Oldham MS; Patel A; Li M; Gazina E; Petrou S; Cilio MR
    Epilepsia; 2018 Oct; 59(10):1889-1898. PubMed ID: 30182418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinidine therapy for West syndrome with KCNTI mutation: A case report.
    Fukuoka M; Kuki I; Kawawaki H; Okazaki S; Kim K; Hattori Y; Tsuji H; Nukui M; Inoue T; Yoshida Y; Uda T; Kimura S; Mogami Y; Suzuki Y; Okamoto N; Saitsu H; Matsumoto N
    Brain Dev; 2017 Jan; 39(1):80-83. PubMed ID: 27578169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic and clinical analysis of children with early-onset epilepsy encephalopathy caused by KCNT1 gene mutation].
    Chen Y; Bao XH; Zhang QP; Wang JP; Wen YX; Yu SJ; Zhao Y
    Zhonghua Er Ke Za Zhi; 2018 Nov; 56(11):824-828. PubMed ID: 30392206
    [No Abstract]   [Full Text] [Related]  

  • 13. New use for an old drug: quinidine in KCNT1-related epilepsy therapy.
    Liu R; Sun L; Wang Y; Wang Q; Wu J
    Neurol Sci; 2023 Apr; 44(4):1201-1206. PubMed ID: 36437393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A quinidine non responsive novel KCNT1 mutation in an Indian infant with epilepsy of infancy with migrating focal seizures.
    Madaan P; Jauhari P; Gupta A; Chakrabarty B; Gulati S
    Brain Dev; 2018 Mar; 40(3):229-232. PubMed ID: 29037447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and molecular characterization of
    McTague A; Nair U; Malhotra S; Meyer E; Trump N; Gazina EV; Papandreou A; Ngoh A; Ackermann S; Ambegaonkar G; Appleton R; Desurkar A; Eltze C; Kneen R; Kumar AV; Lascelles K; Montgomery T; Ramesh V; Samanta R; Scott RH; Tan J; Whitehouse W; Poduri A; Scheffer IE; Chong WKK; Cross JH; Topf M; Petrou S; Kurian MA
    Neurology; 2018 Jan; 90(1):e55-e66. PubMed ID: 29196579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KCNT1 epilepsy with migrating focal seizures shows a temporal sequence with poor outcome, high mortality and SUDEP.
    Kuchenbuch M; Barcia G; Chemaly N; Carme E; Roubertie A; Gibaud M; Van Bogaert P; de Saint Martin A; Hirsch E; Dubois F; Sarret C; Nguyen The Tich S; Laroche C; des Portes V; Billette de Villemeur T; Barthez MA; Auvin S; Bahi-Buisson N; Desguerre I; Kaminska A; Benquet P; Nabbout R
    Brain; 2019 Oct; 142(10):2996-3008. PubMed ID: 31532509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of anti-seizure medications and alternative therapies (ketogenic diet, CBD, and quinidine) in KCNT1-related epilepsy: A systematic review.
    Gras M; Bearden D; West J; Nabbout R
    Epilepsia Open; 2024 Aug; 9(4):1176-1191. PubMed ID: 39093319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted treatment of migrating partial seizures of infancy with quinidine.
    Bearden D; Strong A; Ehnot J; DiGiovine M; Dlugos D; Goldberg EM
    Ann Neurol; 2014 Sep; 76(3):457-61. PubMed ID: 25042079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A recurrent KCNT1 mutation in two sporadic cases with malignant migrating partial seizures in infancy.
    Ishii A; Shioda M; Okumura A; Kidokoro H; Sakauchi M; Shimada S; Shimizu T; Osawa M; Hirose S; Yamamoto T
    Gene; 2013 Dec; 531(2):467-71. PubMed ID: 24029078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in KCNT1 cause a spectrum of focal epilepsies.
    Møller RS; Heron SE; Larsen LH; Lim CX; Ricos MG; Bayly MA; van Kempen MJ; Klinkenberg S; Andrews I; Kelley K; Ronen GM; Callen D; McMahon JM; Yendle SC; Carvill GL; Mefford HC; Nabbout R; Poduri A; Striano P; Baglietto MG; Zara F; Smith NJ; Pridmore C; Gardella E; Nikanorova M; Dahl HA; Gellert P; Scheffer IE; Gunning B; Kragh-Olsen B; Dibbens LM
    Epilepsia; 2015 Sep; 56(9):e114-20. PubMed ID: 26122718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.